Menu Search
Equities

Solarvest BioEnergy Inc

0ZJ:MUN

Solarvest BioEnergy Inc

Actions
  • Price (EUR)0.016
  • Today's Change0.00 / 0.00%
  • Shares traded--
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes, as of Sep 05 2023 07:26 BST.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Profile data is unavailable for this security.

About the company

Solarvest BioEnergy Inc. is a Canada-based algae biologics company. It is focused on three divisions: organic Omega-3 docosahexaenoic acid (DHA), protein expression and bio-hydrogen. Its flexible production platform is capable of producing numerous product lines for different usage. It has developed and patented Omega-3 that is ocean-based (DHA and Eicosapentaenoic Acid (EPA)) and organic. The products are produced without chemicals, solvents and/or heavy processing that degrade the nutritional benefits. It offers a plant-based and sustainable product while avoiding ocean-based toxins/pollutants or residual processing solvents. Its project focuses on cannabinoids, which implements a research and development program to produce cannabidiol (CBD), cannabigerol (CBG) and tetrahydrocannabinol (THC). It has also produced Bone Morphogenetic Protein (BMP) in micro algae. Its solar harvesting technology uses the sun, algae, and water to produce clean fuel with no carbon dioxide (CO2) footprint.

  • Revenue in CAD (TTM)290.00
  • Net income in CAD-1.32m
  • Incorporated2005
  • Employees--
  • Location
    Solarvest BioEnergy Inc301 - 1228 Hamilton StreetVANCOUVER V6B 6L2CanadaCAN
  • Phone+1 (604) 684-3323
  • Fax+1 (604) 239-0728
  • Websitehttp://www.solarvest.ca/
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.